Skip to main content

Table 1 Patient and tumour characteristics

From: Radiogenomic analysis of primary breast cancer reveals [18F]-fluorodeoxglucose dynamic flux-constants are positively associated with immune pathways and outperform static uptake measures in associating with glucose metabolism

Patients (N)

Total recruited

41

With PET data available

36

With PET and mRNA sequencing data available

31

Analysed

30

ER/HER2 status (N)

ER positive/negative

22/8

HER2 positive/negative

5/25

Triple negative (ER negative and HER2 negative)

8

Tumour type (N)

Ductal/lobular/mixed carcinoma

24/4/2

Grade 1/2/3

1/15/14

Characteristics of 30 patients analysed (median, range)

Age at study entry (years)

50 (34–67)

Tumour size on MRI scan (mm)

48 (30–118)

Body mass index

26.2 (19.6–44.9)